{
    "clinical_study": {
        "@rank": "89025", 
        "acronym": "CRITISCH", 
        "arm_group": [
            {
                "arm_group_label": "Endovascular treatment", 
                "description": "Angioplasty +/- stent"
            }, 
            {
                "arm_group_label": "Open treatment", 
                "description": "Bypass (vein or prosthetic)"
            }, 
            {
                "arm_group_label": "Patchplasty/Hybrid treatment", 
                "description": "Femoral artery patchplasty +/- profundoplasty +/- endovascular treatment"
            }, 
            {
                "arm_group_label": "Conservative treatment", 
                "description": "no vascular intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The principal research question is which treatment modality between open surgical,\n      endovascular and conservative therapy is the most effective in terms of limb salvage,\n      survival and reinterventions in patients with critical limb ischemia"
        }, 
        "brief_title": "Registry of First-line Treatments in Patients With Critical Limb Ischemia", 
        "completion_date": {
            "#text": "January 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Critical Limb Ischemia", 
        "condition_browse": {
            "mesh_term": "Ischemia"
        }, 
        "detailed_description": {
            "textblock": "The target population consists of patients suffering from critical limb ischemia (CLI)\n      lasting more than 2 weeks. CLI is defined as rest pain or tissue loss (Fontaine stages\n      III-IV or Rutherford classes 4 to 6) and/or ankle-brachial index < 0.40. Patient with acute\n      limb-threatening ischemia, bone fractures in the relevant areas, nonatherosclerotic disease\n      (e.g. arteriitis) and documented hypercoagulable diseases will be excluded from this study.\n      There will be no experimental or control groups. The comparison groups will be:\n\n      Group 1: Best endovascular treatment (angioplasty +/- stent) Group 2: Best surgical\n      treatment [bypass (vein or prosthetic)] Group 3: Femoral artery patchplasty +/-\n      profundoplasty (+/- endovascular treatment) Group 4: Best conservative treatment\n\n      The proposed sample size amounts to 1200 patients.\n\n      To be assessed for eligibility (n=1200) To be allocated to trial (n=1000) To be analysed\n      (n=900)\n\n      In CRITISCH registry, randomization or blinding is not feasible, because optimized standard\n      care will be performed as established at each participating centre (best medical treatment).\n      Data storage, validation, monitoring, update, backup and analysis will be performed\n      centrally following established procedures. Web-based software will be used to develop a\n      data model representing the data structure. The data validation will include standard data\n      validation techniques such as the manual review of selected variables and the routine check\n      of missing and outlying data points. Regional staff will be instructed and supervised by\n      study nurse, who will perform the study monitoring. Assessment of relevant prognostic\n      factors during the statistical analysis will prevent biased results due to the\n      non-randomized design and the potential structural inequality."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Rest pain or tissue loss (Fontaine stages III-IV or Rutherford classes 4 to 6) and/or\n             ankle-brachial index < 0.40\n\n        Exclusion Criteria:\n\n          -  Acute limb-threatening ischemia\n\n          -  Bone fractures in the relevant areas\n\n          -  Non-atherosclerotic disease (e.g. arteriitis)\n\n          -  Documented hypercoagulable diseases"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The target population consists of patients suffering from critical limb ischemia lasting\n        more than 2 weeks"
            }
        }, 
        "enrollment": {
            "#text": "1200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01877252", 
            "org_study_id": "CRITISCH132105"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Open treatment", 
                    "Patchplasty/Hybrid treatment"
                ], 
                "intervention_name": "Surgical revascularization", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "Vein", 
                    "PTFE", 
                    "Dacron", 
                    "Femoral artery patchplasty", 
                    "Profunda patchplasty"
                ]
            }, 
            {
                "arm_group_label": [
                    "Endovascular treatment", 
                    "Patchplasty/Hybrid treatment"
                ], 
                "intervention_name": "Endovascular revascularization", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "Balloon angioplasty", 
                    "Stent", 
                    "Drug-eluting balloon", 
                    "Drug-eluting stent", 
                    "Lysis"
                ]
            }, 
            {
                "arm_group_label": "Conservative treatment", 
                "intervention_name": "No vascular intervention", 
                "intervention_type": "Other", 
                "other_name": [
                    "Major amputation", 
                    "Minor amputation", 
                    "Sympatholysis", 
                    "Conservative treatment"
                ]
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "critical limb ischemia", 
            "endovascular treatment", 
            "open surgical repair", 
            "diabetic foot"
        ], 
        "lastchanged_date": "June 10, 2013", 
        "link": [
            {
                "description": "Department of Vascular Surgery, St. Franziskus Hospital", 
                "url": "http://www.sfh-muenster.de/de/medizinische-kompetenzen/gefaesschirurgie/das-aerzteteam.html"
            }, 
            {
                "description": "Deutsches Institut f\u00fcr Gef\u00e4\u00dfmedizinische Gesundheitsforschung (DIGG)", 
                "url": "http://www.digg-dgg.de"
            }, 
            {
                "description": "German Society for Vascular Surgery and Medicine", 
                "url": "http://www.gefaesschirurgie.de"
            }
        ], 
        "location": {
            "contact": {
                "email": "theodosios.bisdas@ukmuenster.de", 
                "last_name": "Theodosios Bisdas, MD", 
                "phone": "+492518345782"
            }, 
            "facility": {
                "address": {
                    "city": "Muenster", 
                    "country": "Germany", 
                    "zip": "48145"
                }, 
                "name": "Department of Vascular Surgery, St. Franziskus Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "4", 
        "official_title": "National Registry Investigating the Effectiveness of Different First-line Treatment Strategies in Patients With Critical Limb Ischemia", 
        "overall_contact": {
            "email": "theodosios.bisdas@ukmuenster.de", 
            "last_name": "Theodosios Bisdas, MD", 
            "phone": "+492518345782"
        }, 
        "overall_contact_backup": {
            "email": "giovanni.torsello@ukmuenster.de", 
            "last_name": "Giovanni Torsello, MD, PhD", 
            "phone": "+492518345782"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: German Society of Vascular Surgery and Medicine (DGG) and Deutsches Insitut f\u00fcr Gef\u00e4\u00dfmedizinische Gesundheitsforschung gGmbH (DIGG)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Above-ankle amputation of the index limb or death (any cause), whichever occurred first", 
            "measure": "Amputation-free survival", 
            "safety_issue": "Yes", 
            "time_frame": "at 2 years"
        }, 
        "reference": [
            {
                "PMID": "22172473", 
                "citation": "Setacci C, de Donato G, Teraa M, Moll FL, Ricco JB, Becker F, Robert-Ebadi H, Cao P, Eckstein HH, De Rango P, Diehm N, Schmidli J, Dick F, Davies AH, Lep\u00e4ntalo M, Apelqvist J. Chapter IV: Treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg. 2011 Dec;42 Suppl 2:S43-59. doi: 10.1016/S1078-5884(11)60014-2. Review."
            }, 
            {
                "PMID": "22172472", 
                "citation": "Becker F, Robert-Ebadi H, Ricco JB, Setacci C, Cao P, de Donato G, Eckstein HH, De Rango P, Diehm N, Schmidli J, Teraa M, Moll FL, Dick F, Davies AH, Lep\u00e4ntalo M, Apelqvist J. Chapter I: Definitions, epidemiology, clinical presentation and prognosis. Eur J Vasc Endovasc Surg. 2011 Dec;42 Suppl 2:S4-12. doi: 10.1016/S1078-5884(11)60009-9. Review."
            }, 
            {
                "PMID": "16325694", 
                "citation": "Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H; BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005 Dec 3;366(9501):1925-34."
            }, 
            {
                "PMID": "20435258", 
                "citation": "Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, Ruckley CV, Raab GM; BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010 May;51(5 Suppl):5S-17S. doi: 10.1016/j.jvs.2010.01.073. Erratum in: J Vasc Surg. 2010 Dec;52(6):1751. Bhattachary, V [corrected to Bhattacharya, V]."
            }, 
            {
                "PMID": "19897335", 
                "citation": "Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR, Moneta GL, Nehler MR, Powell RJ, Sidawy AN. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg. 2009 Dec;50(6):1462-73.e1-3. doi: 10.1016/j.jvs.2009.09.044. Epub 2009 Nov 7. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01877252"
        }, 
        "responsible_party": {
            "investigator_affiliation": "St. Franziskus Hospital", 
            "investigator_full_name": "Dr. Theodosios Bisdas", 
            "investigator_title": "Dr. med.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Perioperative death", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "description": "above ankle amputation of the index limb or major intervention (new bypass graft, jump/interposition graft revision, or thrombectomy/thrombolysis)", 
                "measure": "Major adverse limb event (MALE)", 
                "safety_issue": "Yes", 
                "time_frame": "at 1 year, at 2 years"
            }, 
            {
                "description": "myocardial infarction, stroke or death (any cause)", 
                "measure": "Major adverse cardiovascular event (MACCE)", 
                "safety_issue": "Yes", 
                "time_frame": "at 30 days, at 1 year, at 2 years"
            }, 
            {
                "description": "upward shift on the Rutherford or Fontaine classification to a level of intermittent claudication in amputation-free surviving patients without the need for repeated target lesion revascularization (TLR) (primary improvement) or after repeated TLR (secondary improvement)", 
                "measure": "Sustained clinical improvement", 
                "safety_issue": "No", 
                "time_frame": "at 1 year, at 2 years"
            }, 
            {
                "description": "first occurrence of any of the following events in a time-to-event fashion: (a) major amputation (transtibial or above) and/or (b) reintervention to maintain vascular patency in the index limb and/or (c) failure to increase ankle-brachial-index (ABI) by at least 0.15 postprocedure] and/or (d) decrease in ABI by 0.15", 
                "measure": "Hemodynamic failure", 
                "safety_issue": "No", 
                "time_frame": "at 30 days, at 1 year, at 2 years"
            }
        ], 
        "source": "St. Franziskus Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Deutsches Institut f\u00fcr Gef\u00e4\u00dfmedizinische Gesundheitsforschung gGmbH (DIGG)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Deutsche Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie und Gef\u00e4\u00dfmedizin", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "St. Franziskus Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "2 Years", 
        "verification_date": "June 2013"
    }
}